Abstract
Cryptococcosis is a major opportunistic mycosis which has meningitis as its most frequent clinical presentation and can be fatal in the absence of antifungal therapy. The aetiological agents are Cryptococcus neoformans, which affects mainly immunocompromised subjects, and C. gattii, the aetiologic agent for cryptococcosis in healthy individuals. A recent outbreak of cryptococcosis on Vancouver Island, Canada, raised the level of concern about the epidemiology of this disease. In Brazil, between 1980 and 2002, six per cent of AIDS patients had cryptococcosis in course at the time of diagnosis. To identify the profile of cryptococcal meningitis patients in Rio Grande do Sul (RS), Brazil, a retroactive study was realized using data from patients registered at Laboratório Central de Saúde Pública IPB-LACEN/RS from 2000 to 2005. Most of the patients were men (77.12%), Caucasian (83.5%), median age between thirty and thirty-nine years old (46.24%) and HIV positive (95%).
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Cryptococcosis is an infection manifested mainly as lung disease or meningitis, which can be rapidly fatal if untreated. This infection can be caused by both Cryptococcus neoformans and Cryptococcus gattii. C. neoformans var. grubii (serotype A) and C. neoformans var. neoformans (serotype D) are cosmopolitan and affect mostly immunocompromised individuals, especially those infected by HIV. Cryptococcus gattii affects healthy individuals and was considered to be restricted to tropical and subtropical regions of the world [1, 2] until recently, when it was isolated from humans, animals and from many different environmental locations on Vancouver Island, British Columbia, and from surrounding areas of the Canadian and USA mainland [3–6].
In Brazil, 215,810 cases of AIDS were registered from 1980 to 2002. Six per cent of these patients had cryptococcosis in course at the time of diagnosis [7]. Several molecular typing methods have been used in epidemiological analysis of clinical and environmental isolates of C. neoformans and C. gattii and important reports have shown the epidemiological aspects of isolates of these yeasts in Rio Grande do Sul state [8–10]. However, these reports did not explore the patients’ characteristics. Considering the importance of this disease and the lack of data about those patients, a retrospective investigation was conducted in order to verify the profile of patients with cryptococcal meningitis in South Brazil.
Patients and Methods
Data from 126 patients with cryptococcal meningitis who reported to the Laboratório Central de Saúde Pública IPB-LACEN/RS between 2000 and 2005 were used to assess the epidemiological profile of the cryptococcal meningitis patients. The parameters considered for analysis were race, gender, age, HIV and other risk factors for the disease and related symptoms. The number of patients (n) for each parameter was variable, according to the data available, as not all the records were properly filled in. A control group was formed with 220 patients who were suspected to have meningitis, but whose cerebrospinal fluid (CSF) had shown negative results for C. neoformans and C. gattii using India ink preparations, culture in Sabouraud Dextrose Agar, and latex agglutination test. The statistical analyses were performed using the χ2 test with or without the Yates correction and Kappa test (SPSS vs. 13.0).
Results and Discussion
Epidemiological analysis revealed that the majority of patients were men (77.12%), Caucasian (83.5%) and HIV infected (95%). The data are summarized in Table 1. Most patients were between 30 and 39 years old (46.24%) (Table 2). Race, HIV infection and age were statistically different (χ2 P = 0.0001) between patient and control groups. The symptoms were mainly chronic headache (80%), fever (22.86%), vomiting (17.14%), sensory loss (14.29%) and stiff neck (11.43%). Chronic headache, sensory loss and stiff neck were statistically different (χ2 P = 0.0001) between patient and control groups.
We found 95.42% (126 samples) of C. neoformans var. grubii (serotype A) and 4.58% (6 samples) of C. gattii (serotype B). These data are in agreement with the world literature, which points out as predominant the infection caused by variety grubii [1, 11]. Cryptococcus neoformans var. neoformans (serotype D), which is predominant in temperate climates, was not found. A previous study conducted in our state showed a prevalence of 89.52% and 10.48% for the varieties grubii and gattii, respectively. However, the percentage of C. gattii might be overestimated, since the samples were not randomly obtained [8].
Regarding the epidemiological profile, 95% of the patients were HIV positive, reinforcing the HIV infection as the main risk factor for cryptococcosis. The frequency of HIV infection was significantly higher in the patients with cryptococcal meningitis than in those of the control group (P = 0.0001). Our results also agree with the literature about gender, finding 77.12% of men compared to 22.88% of women. In France, a study with 2,125 cases showed a men:women ratio of 6.8 among the HIV-infected patients and 1.7 among the non-infected [12]. The IberoAmerican Cryptococcal Study Group, in nine countries including Brazil, obtained 5.1-fold more infected men than women as a research result [13]. Apparently, men are highly susceptible to infections caused by C. neoformans and C. gattii.
Other invasive mycosis also appears to be more frequent in men, such as paracoccidioidomicosis, studies of which have shown the influence of female hormones along the course of infection. For Paracoccidioides brasiliensis, the rate of subclinical infection is the same for both men and women, but the progression of the disease is higher in men. Male and female mice were infected with conidia (infectious form) and, after 48 hours, the conidia had started to develop into yeast (pathogenic form) in males, but not in females [14, 15]. It is possible that female hormones have an important role in host defence against cryptococcosis; yet, in studies with mice, females infected with C. neoformans produced higher levels of cytokines in plasma and higher levels of TNF-α and IFN-γ in spleen and blood than did males [16].
Most cases (46.24%) occurred in 30–39-year-olds, which was statistically different from the control group (P = 0.0001). Similar data was found in Austria, Germany and Switzerland, where the age group comprehended 31 and 40 years old for men and 21 and 30 years old for women [17]. In France, Dromer et al. [12] found an age group between 26 and 35 years old for HIV-positive patients and more than 46 years old for HIV-negative patients.
The median age in our study was 36.36 years old, similarly to those found in Africa (34.25 years old) [18] and France (33 years old for females and 36 for males) [12]. In Australia, two independent studies showed differences in the median age between men and women, being 39 years old for men and 46 for women in 18 patients [19] and 36.8 years old for men and 47.7 years old for women in a study of 350 patients [20]. The data in the literature suggest that the median age for cryptococcosis patients is higher in women than in men and higher in HIV-negative patients than in those infected by HIV.
HIV was not the only risk factor for cryptococcal infections reported in our patients. The use of intravenous drugs was reported in eight patients; alcoholism, smoking and malnutrition in two different patients; tuberculosis, formation of tumours, use of antitumoral drugs, hepatitis C, cirrhosis and a workplace with pigeon presence had one patient per factor (Fig. 1). We did not have information about a possible HIV infection in one patient with malnutrition and the one who reported working in a place with pigeon presence. All the other conditions were AIDS associated, except for one patient who was HIV negative and presented malnutrition as a unique predisposing condition.
Chen et al. [20] suggested the need for exploring risk factors not yet studied, such as genetic susceptibility and socio-economic and nutritional status. However, no other reports were found about malnutrition as the only risk factor for infection by C. neoformans var. grubii. Cancer, cirrhosis, alcoholism, use of antitumoral drugs, tuberculosis, hepatitis C and malnutrition have already been associated with cryptococcosis in patients with or without AIDS [21–23]. Kiertiburanakul et al. [24] stated immunosuppressive therapies as the main predisposing factor (41%) in HIV-negative patients, followed by systemic lupus erythematosus and cancer (16% each).
Analysis concerning race demonstrated that there was an evident Caucasian race predominance, corresponding to 83.5% of patients and being statistically different when compared with the control group (P = 0.0001). This statistical difference could reveal the Caucasian race as a risk factor for cryptococcosis, disagreeing with data obtained by Hajjeh et al. [25] that showed a higher ratio for African Americans (31/1,000) than for Caucasians (23/1,000) with AIDS, but the comparison to the control group was not statistically significant. A subsequent study also demonstrated a higher ratio of infection among the African American HIV-positive patients than for Caucasian HIV-positive patients. In this work, they suggested that the prevalence of infection in African Americans was not directly related to cryptococcosis, but related to the privation of access to basic care for AIDS treatment, since most of the isolates were obtained from public hospitals [26]. To summarize, no clear relationship was found between race and cryptococcosis.
Concerning the symptoms, only three were statistically dissimilar from those reported by the patients in the control group (P = 0.0001). These were headache (80%), sensory loss (14.29%) and stiff neck (11.43%). In another Brazilian study, from Bahia State, 104 patient records of cryptococcosis patients were analysed and the most frequent symptoms reported were headache (92.7%), fever (84.4%) and stiff neck (83.2%) [27].
To our knowledge, this is the first study to assess the epidemiological profile of patients with cryptococcal meningitis in the Brazilian state Rio Grande do Sul. This is an important contribution to the knowledge about this disease because, until now, in this state, there were just a few case reports [28–30] or studies mainly focusing on the epidemiological characteristics of the yeast rather than on the patients themselves.
References
Idnurm A, Bahn YS, Nielsen K, Lin X, Fraser JA, Heitman J. Deciphering the model pathogenic fungus Cryptococcus neoformans. Nat Rev Microbiol. 2005;3:753–64.
Kwon-Chung KJ, Boekhout T, Fell JW, Diaz M. Proposal to conserve the name Cryptococcus gatti against C. hondurianus and C. bacillisporus. Taxon. 2002;51:804–6.
Kidd SE, Bach PJ, Hingston AO, Mak S, Chow Y, MacDougall L, Kronstad JW, Bartlett KH. Cryptococcus gattii dispersal mechanisms, British Columbia, Canada. Emerg Infect Dis. 2007;13:51–7.
MacDougall L, Fyfe M. Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J Clin Microbiol. 2006;44:1851–2.
Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, MacDougall L, Boekhout T, Kwon-Chung KJ, Meyer W. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA. 2004;101:17258–63.
Stephen C, Lester S, Black W, Fyfe M, Raverty S. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can Vet J. 2002;43:792–4.
Ministério da Saúde do Brasil. Dados e pesquisa em DSTs e Aids. Coordenação do programa nacional de DST/Aids. Brasília, DF; 2002.
Casali AK, Goulart L, Rosa e Silva LK, Ribeiro AM, Amaral AA, Alves SH, Schrank A, Meyer W, Vainstein MH. Molecular typing of clinical na environmental Cryptococcus neoformans in the Brazilian state Rio Grande do Sul. FEMS Yeast Res. 2003;3:405–15.
Horta JA, Staats CC, Casali AK, Ribeiro AM, Schrank IS, Shrank A, Vainstein MH. Epidemiological aspects of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul. Med Mycol. 2002;40:565–71.
Abegg MA, Cella FL, Faganello J, Valente P, Schrank A, Vainstein MH. Cryptococcus neoformans and Cryptococcus gattii isolated from the excreta os Psittaciformes in a Southern Brazilian Zoological Garden. Mycopathologia. 2006;161:83–91.
Casadevall A, Perfect JR. Cryptococcus neoformans. Washington: ASM Press; 1998.
Dromer F, Mathoulin-Pèlissier S, Fontanet A, Ronin O, Dupont B, Lortholary O, French Cryptococcosis Study Group. Epidemiology of HIV-associated cryptococcosis in France (1985–2001): comparison of the pre- and post-HAART eras. AIDS. 2004;18:555–62.
Meyer W, Castañeda A, Jackson S, Huynh M, Catañeda E, IberoAmerican Cryptococcal Study Group. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis. 2003;9:189–95.
Aristizabal BH, Clemons KV, Stevens DA, Restrepo A. Morphological transition of Paracoccidioides brasiliensis conidia to yeast cells: in vivo inhibition in females. Infect Immun. 1998;66:5587–91.
Borges-Walmsley MI, Chen D, Shu X, Walmsley AR. The pathobiology of Paracoccidioides brasiliensis. Trends Microbiol. 2002;10:80–7.
Lortholary O, Improvisi L, Fitting C, Cavaillon M, Dromer F. Influence of gender and age on course of infection and cytokine responses in mice with disseminated Cryptococcus neoformans infection. Clin Microbiol Infect. 2002;8:31–7.
Tintelnot K, Lemmer K, Losert H, Schär G, Polak A. Follow-up of epidemiological data of cryptococcosis in Austria, Germany and Switzerland with special focus on the characterization of clinical isolates. Mycoses. 2004;47:455–64.
Millogo A, Ki-Zerbo GA, Andonaba JB, Lankoandé D, Sawadogo A, Yameógo I, Sawadogo AB. Cryptococcal meningitis in HIV-infected patients at Bobo-Dioulasso hospital (Burkina Faso). Bull Soc Pathol Exot. 2004;97:119–21.
Jenney A, Pandithage K, Fisher DA, Currie BJ. Cryptococcus infection in Tropical Australia. J Clin Microbiol. 2004;42:3865–68.
Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, Marriott D, Pfeiffer T, Parr D, Byth K. Epidemiology and host- and variety-dependent characteristics of Infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis. 2000;31:499–508.
Friedman GD, Jeffrey Fessel W, Udalsova NV, Hurley LB. Cryptococcosis: the 1981–2000 epidemic. Mycoses. 2005;48:122–5.
El-Serag HB, Anand B, Richardson P, Rabeneck L. Association between hepatitis C infection and other infectious diseases: a case for targeted screening? Am J Gastroenterol. 2003;98:167-74.
Awasthi M, Patankar T, Shah P, Castillo M. Cerebral cryptococcosis: atypical appearances on CT. Br J Radiol. 2001;74:83–5.
Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S. Cryptococcosis in human immunodeficiency virus-negative patients. Int J Infect Dis. 2006;10:72–8.
Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, Pappas PG, Thomas C, Reingold A, Rothrock G, Hutwagner LC, Schuchat A, Brandt ME, Pinner RW. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. J Infect Dis 1999;179:449–54.
Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Gardner T, Sattah M, de Leon GP, Baughman W, Hajjeh RA. The changing epidemiology of Cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992–2000. Clin Infect Dis. 2003;36:789–94.
Darzé C, Lucena R, Gomes I, Melo A. The clinical laboratory characteristics of 104 cases of cryptococcal meningoencephalitis. Rev Soc Bras Med Trop. 2000;33:21–6.
Severo LC, Oliveira FM, Londero AT. Cryptococcosis due to Cryptococcus neoformans var. gattii in Brazilian patients with AIDS. Report of three cases. Rev Iberoam Micol. 1999;16:152–4.
Lopes JO, Costa JM, Streher LA, Clock C, Pinto MS, Alves SH. Cryptococcosis not related to AIDS in Rio Grande do Sul: a report of 8 cases and a review of the literature. Rev Soc Bras Med Trop. 1997;30:369–72.
Fontana MH, Coutinho MF, Camargo ES, Soviero B, Lima SS, Matusiak R, Dias CG. Neurocryptococcosis in childhood. Report of 3 cases in the 1st decade of life. Arq Neuropsiquiatr. 1987;45:403–11.
Acknowledgements
This work was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação Estadual de Produção e Pesquisa em Saúde (FEPPS) and Fundação de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leal, A.L., Faganello, J., Fuentefria, A.M. et al. Epidemiological Profile of Cryptococcal Meningitis Patients in Rio Grande do Sul, Brazil. Mycopathologia 166, 71–75 (2008). https://doi.org/10.1007/s11046-008-9123-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-008-9123-2